Tolaymat B1, Zheng W2, Chen H1, Choi S1, Li X3, Harrison Dm4. 1. University of Maryland School of Medicine, Baltimore, MD, United States. 2. Department of Neurology, Greater Baltimore Medical Center, Baltimore, MD, United States. 3. F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, United States; Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States. 4. University of Maryland School of Medicine, Baltimore, MD, United States; Department of Neurology Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Neurology, University of Maryland School of Medicine, 110 South Paca Street, 3(rd) Floor, Baltimore, Maryland 201201. Electronic address: dharrison@som.umaryland.edu.
Abstract
BACKGROUND: Susceptibility MRI techniques, such as phase and quantitative susceptibility mapping (QSM) reveal lesion heterogeneity in MS, including the presence of lesions with outer rims suggestive of iron accumulation in macrophages and microglia, indicative of chronic-active inflammatory white matter lesions (WMLs). OBJECTIVE: To evaluate the in vivo relationship between chronic-active WMLs (as visualized by rimmed lesions on QSM) and several clinical metrics. METHODS: 39 patients (15 men, 24 women) with MS underwent 7 Tesla brain MRIs and clinical evaluation. Contrast patterns of lesions identified on FLAIR and quantitative susceptibility maps were reviewed and compared to demographic characteristics and disability scores. RESULTS: 1279 lesions were identified on FLAIR MRI; 846 (66.2%) of these were visible on QSM, 119 (14.1%) of which had visible rims. Lesions visible on QSM were more likely to have rims in men (16.1%, vs 4.9% in women, p=0.009). In a logistic regression model accounting for several factors, male sex conferred a >10-fold risk of having ≥1 rimmed lesion(s) (p=0.026). CONCLUSION: Our findings provide in vivo support for the body of histopathologic literature indicating sex-specific differences in MS WML formation and suggest that QSM can be used to study these sex differences in the future.
BACKGROUND: Susceptibility MRI techniques, such as phase and quantitative susceptibility mapping (QSM) reveal lesion heterogeneity in MS, including the presence of lesions with outer rims suggestive of iron accumulation in macrophages and microglia, indicative of chronic-active inflammatory white matter lesions (WMLs). OBJECTIVE: To evaluate the in vivo relationship between chronic-active WMLs (as visualized by rimmed lesions on QSM) and several clinical metrics. METHODS: 39 patients (15 men, 24 women) with MS underwent 7 Tesla brain MRIs and clinical evaluation. Contrast patterns of lesions identified on FLAIR and quantitative susceptibility maps were reviewed and compared to demographic characteristics and disability scores. RESULTS: 1279 lesions were identified on FLAIR MRI; 846 (66.2%) of these were visible on QSM, 119 (14.1%) of which had visible rims. Lesions visible on QSM were more likely to have rims in men (16.1%, vs 4.9% in women, p=0.009). In a logistic regression model accounting for several factors, male sex conferred a >10-fold risk of having ≥1 rimmed lesion(s) (p=0.026). CONCLUSION: Our findings provide in vivo support for the body of histopathologic literature indicating sex-specific differences in MS WML formation and suggest that QSM can be used to study these sex differences in the future.
Authors: Xu Li; Daniel M Harrison; Hongjun Liu; Craig K Jones; Jiwon Oh; Peter A Calabresi; Peter C M van Zijl Journal: J Magn Reson Imaging Date: 2015-06-14 Impact factor: 4.813
Authors: Daniel M Harrison; Kevin Y Wang; Julie Fiol; Kerry Naunton; Walter Royal; Jun Hua; Izlem Izbudak Journal: J Neuroimaging Date: 2017-05-02 Impact factor: 2.486
Authors: Sabina Luchetti; Corbert G van Eden; Karianne Schuurman; Miriam E van Strien; Dick F Swaab; Inge Huitinga Journal: J Neuropathol Exp Neurol Date: 2014-02 Impact factor: 3.685
Authors: José P Marques; Tobias Kober; Gunnar Krueger; Wietske van der Zwaag; Pierre-François Van de Moortele; Rolf Gruetter Journal: Neuroimage Date: 2009-10-09 Impact factor: 6.556
Authors: D H Miller; P Rudge; G Johnson; B E Kendall; D G Macmanus; I F Moseley; D Barnes; W I McDonald Journal: Brain Date: 1988-08 Impact factor: 13.501
Authors: Karen Ann Ribbons; Patrick McElduff; Cavit Boz; Maria Trojano; Guillermo Izquierdo; Pierre Duquette; Marc Girard; Francois Grand'Maison; Raymond Hupperts; Pierre Grammond; Celia Oreja-Guevara; Thor Petersen; Roberto Bergamaschi; Giorgio Giuliani; Michael Barnett; Vincent van Pesch; Maria-Pia Amato; Gerardo Iuliano; Marcela Fiol; Mark Slee; Freek Verheul; Edgardo Cristiano; Ricardo Fernandez-Bolanos; Maria-Laura Saladino; Maria Edite Rio; Jose Cabrera-Gomez; Helmut Butzkueven; Erik van Munster; Leontien Den Braber-Moerland; Daniele La Spitaleri; Alessandra Lugaresi; Vahid Shaygannejad; Orla Gray; Norma Deri; Raed Alroughani; Jeannette Lechner-Scott Journal: PLoS One Date: 2015-06-05 Impact factor: 3.240
Authors: A Dal-Bianco; R Schranzer; G Grabner; M Lanzinger; S Kolbrink; G Pusswald; P Altmann; M Ponleitner; M Weber; B Kornek; K Zebenholzer; C Schmied; T Berger; H Lassmann; S Trattnig; S Hametner; F Leutmezer; P Rommer Journal: Front Neurol Date: 2021-12-21 Impact factor: 4.003
Authors: Koy Chong Ng Kee Kwong; Daisy Mollison; Rozanna Meijboom; Elizabeth N York; Agniete Kampaite; Michael J Thrippleton; Siddharthan Chandran; Adam D Waldman Journal: PLoS One Date: 2021-09-08 Impact factor: 3.240